MElkin pharmaceuticals is a biopharmaceutical company identifying and developing innovative new treatments for cancer and brain diseases that are associated with aberrant activation of the MAPKinase/ERK signaling pathway.
Founded in 2015, the company is currently engaged in the preclinical development of the PepFos lead compound for cancer treatment.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Orleans
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- melkin-pharma.com
- Keywords
- Drug discovery, Preclinical drug development, Lead selection/ optimization, Drug candidate development, Cell-penetrating peptide.
- HQ
- ORLEANS
Melkin Pharmaceuticals Questions
Melkin Pharmaceuticals's website is melkin-pharma.com
Melkin Pharmaceuticals's LinkedIn profile is https://fr.linkedin.com/company/melkin-pharmaceuticals
Melkin Pharmaceuticals has
3 employees.
View email and phone details for 3
employees at Melkin Pharmaceuticals.
Melkin Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Melkin Pharmaceuticals's top competitors are
Nahibu,
Biocreation Cosmetic,
Laboratoires Téane,
Igyxos,
Spydiag,
Artimmune Sas,
Genel,
Greenpharma S.a.s.,
Dianael,
Agro-Bio Antibodies.
Melkin Pharmaceuticals's categories are Pharmaceutical Manufacturing
Melkin Pharmaceuticals's founding year is 2015
